学习基于生物标志物的慢性疾病最优治疗策略
该研究设计了一套整合流程,利用治疗前静息态脑电图(EEG)特征及其他效应修饰因子,通过因果森林估计条件平均治疗效应,并结合双重稳健技术与策略学习算法,为重度抑郁症患者学习最优的深度2治疗分配决策树,并在EMBARC多中心双盲随机对照试验中验证。
要点
- 治疗前α和θ频段EEG信号与抗抑郁药反应存在一定关联。
- 采用因果森林估计CATE,双重稳健技术提高平均治疗效应估计效率。
- 学习最优深度2治疗分配决策树,并与Q-Learning和结果加权学习比较。
核心结论
- 研究展示了治疗效应的异质性以及EEG特征的修饰作用,并发现显著的平均治疗效应,该结果无法通过传统方法获得。
- 通过策略学习算法学习到最优深度2治疗分配决策树,并在模拟研究和EMBARC试验应用中与Q-Learning及结果加权学习进行了性能比较。
研究设计与样本
- 研究设计了一套整合流程,利用治疗前静息态EEG记录及其他治疗效应修饰因子,为重度抑郁症患者制定治疗策略以提高应答率。
- 首先设计了创新的自动位点特异性EEG预处理流程,以提取比原始数据信号更强的特征。
- 使用因果森林估计条件平均治疗效应(CATE),并采用双重稳健技术提高平均治疗效应估计的效率。
- 采用高效策略学习算法学习最优深度2治疗分配决策树,并通过模拟研究及对大型多中心、双盲、随机对照临床试验EMBARC的应用进行比较。
主要发现
- 治疗前α和θ频段EEG信号与抗抑郁药反应存在一定关联,而抗抑郁药应答率已知较低。
- 研究展示了治疗效应的异质性以及EEG特征的修饰作用。
- 研究发现了显著的平均治疗效应,该结果无法通过传统方法获得。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Electroencephalogram (EEG) provides noninvasive measures of brain activity and is found to be valuable for the diagnosis of some chronic disorders. Specifically, pre-treatment EEG signals in the alpha and theta frequency bands have demonstrated some association with antidepressant response, which is well-known to have a low response rate. We aim to design an integrated pipeline that improves the response rate of patients with major depressive disorder by developing a treatment policy guided by the resting state pre-treatment EEG recordings and other treatment effects modifiers. First, we design an innovative automatic site-specific EEG preprocessing pipeline to extract features with stronger signals than raw data. We then estimate the conditional average treatment effect (CATE) using causal forests and use a doubly robust technique to improve efficiency in the estimation of the average treatment effect. We present evidence of heterogeneity in the treatment effect and the modifying power of the EEG features, as well as a significant average treatment effect, a result that cannot be obtained with conventional methods. Finally, we employ an efficient policy learning algorithm to learn an optimal depth-2 treatment assignment decision tree and compare its performance with Q-Learning and outcome-weighted learning via simulation studies and an application to a large multi-site, double-blind, randomized controlled clinical trial, EMBARC.
引用
- Yang B, Guo X, Loh JM, et al. Learning optimal biomarker-guided treatment policy for chronic disorders. Stat Med. 2024. PMID: 38700103. doi:10.1002/sim.10099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。